Next-Generation Sequencing

Jul 24, 2026

For decades, the diagnosis and monitoring of cancer have depended heavily on tissue biopsy, a procedure that involves surgically or percutaneously removing a piece of tumor for pathological examination. While tissue biopsy remains the diagnostic gold standard, it is invasive, carries procedural risk, cannot always ...

Jul 08, 2026

For decades, prescribing medicine has followed a "one-size-fits-all" playbook: a standard drug, a standard dose, and a hopeful wait to see how the patient responds. The pharmacogenomic testing service is quietly dismantling that model. By reading the genetic variants that govern how an individual absorbs, metaboliz...

Jul 01, 2026

DNA diagnostics is no longer a niche laboratory technique reserved for research institutions, it has become one of the fastest-growing pillars of modern medicine. By analyzing genetic material to detect mutations, pathogens, and chromosomal abnormalities, DNA-based testing is transforming how diseases are predicted...

Mar 25, 2026

Molecular diagnostics is a rapidly advancing field within laboratory medicine that applies molecular biology techniques to detect and quantify specific DNA or RNA sequences. By enabling earlier detection, greater diagnostic accuracy, and more informed clinical decision-making, these technologies have become indispe...

Mar 11, 2026

The landscape of modern medicine is undergoing a profound shift from a "one-size-fits-all" approach to a model that is deeply personalized and data-driven. At the heart of this transformation is the concept of precision medicine, which seeks to tailor medical treatment to the individual characteristics of each pati...

Jan 01, 2026

FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy On December 23, 2025, Edwards Lifesciences announced that its SAPIEN M3 mitral valve replacement system, the first transcatheter therapy using a transseptal approach, received approval from the...